Abstract

Background: Nitrates are highly effective in terminating acute angina pectoris attacks and preventing symptomatic and asymptomatic myocardial ischemia. Methods: This was an observational survey-based study conducted in cardiologists and physicians with clinical expertise in the management of ischemic heart disease from January 2024 to March 2024. Data entry and statistical analysis were done for completed questionnaires and results are expressed in terms of percentages based on the number of responses obtained. Results: A total of 47 clinicians participated in this survey. Nitrates were preferred as first-line agents by 59.5% of respondents, while 40.5% favoured beta blockers. Headache (51.0%) was the most common reason for shifting from nitro-glycerine to other anti-anginal. Most clinicians (76.5%) co-prescribed beta blockers with nitrates, while 6.3% co-prescribed calcium channel blockers. Conclusions: The present survey concluded that nitrates continue to be the preferred anti-angina drugs in the real-world setting in India.